Inventor

KRUSE LAWRENCE I

US47 patents

⚠️ This page may combine multiple inventors who share the name “KRUSE LAWRENCE I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KRUSE LAWRENCE I

SMITHKLINE BECKMAN CORP

2-mercaproimidazole dopamine-β-hydroxylase inhibitors

Irreversible dopamine-β-hydroxylase inhibitors

1-Benzyl-2-aminomethyl imidazole derivatives

Dopamine-beta-hydroxylase inhibitors

Imidazolethiol dopamine-beta-hydroxylase inhibitors

Substituted te[1]trahydroisoquinoline derivatives having β-adrenergic receptor activity

Pyridylalkyl imidazole-2-thiols

Semicarbazide intermediates for preparing 4-substituted indoles

Processes for preparing 4-substituted indoles

1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors

1-substituted-2-mercapto benzimidazole compounds and intermediates

Dopamine-β-hydroxylase inhibitors and use thereof

Dopamine-β-hydroxylase inhibitors

2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors

3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors

Dopamine β-hydroxylase inhibitors

Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity

1-aralkyl-2-mercaptoimidazolines as DBH inhibitors

Dopamine-β-hydroxylase inhibitors

Dopamine-beta-hydroxylase inhibitors

Dopamine-β-hydroxylase inhibitors

Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors

Dopamine-β-hydroxylase inhibitors

Dopamine-beta-hydroxylase inhibitors

Substituted tetrahydro isoquinoline intermediates

P-toluene-sulfonyl-oxy substituted pyridines

Intermediate to dopamine-β-hydroxylase inhibitors

Dopamine-β-hydroxylase inhibitors

ADOLOR CORP

Kappa agonist compounds and pharmaceutical formulations thereof

Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Kappa agonist compounds and pharmaceutical formulations thereof

Kappa agonist compounds and pharmaceutical formulations thereof

Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Kappa agonist compounds and pharmaceutical formulations thereof

Kappa agonist compounds and pharmaceutical formulations thereof

Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Kappa agonist compounds and pharmaceutical formulations thereof

SANSHIN KOGYO KK

2-(substituted phenyl)-4-oxo-quinazolines

SMITHKLINE BEECHAM PLC

Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists

SMITHKLINE BEECHAM CORP

Dopamine-β-hydroxylase inhibitors

SYMPHAR SA

Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted G-em-diphosphonates and process of use to treat hyperlipidemia

SMITHKLEIN BECKMAN CORP

Dopamine-β-hydroxylase inhibitors

BRUNTON SHIRLEY ANN

Small organic molecule regulators of cell proliferation

SMITH KLINE FRENCH LAB

Heterocyclic compounds

(unassigned)

Antimicrobial agent for agriculture